Highs & Lows: Teva Pharmaceutical, Best Buy, and Tellabs
News | 27 December 2012
Today's resumed budget talks are ramping up investor anxiety, as U.S. indices are sagging considerably in the red. A mixed bag of economic data -- including a drop in first-time jobless claims and a dip in consumer confidence -- hasn't helped to draw ...
Click on the link to read the full article at Schaeffers Research (blog)
(This link will open in a new window)
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
